A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)

Phase 4

Completed

• Conditions: Rheumatoid Arthritis

• Registration Number: NCT00157872
• Lead Sponsor: Merck Sharp & Dohme LLC

Brief Summary

A study to compare rofecoxib versus naproxen in the treatment of Chinese patients with rheumatoid arthritis.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-01-07
• Primary Completion: 2004-07-05
• Study Completion: 2004-09-19
• Study First Submitted: 2005-09-07
• Study First Submitted QC: 2005-09-07
• Study First Posted: 2005-09-12
• Status Verified: 2017-05
• Last Update Submitted: 2017-05-23
• Last Update Posted: 2017-05-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• Chinese males or females at least 18 years of age with rheumatoid arthritis

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Tender joint count
swollen joint count
patient's global assessment of disease activity
investigator's global assessment of disease activity

Secondary Outcome Measures

Name	Time	Method
Patient pain assessment
patient's global assessment of response to therapy
investigator's global assessment of response to therapy